MonaFit™
Liver Health

  • Supports Healthy Liver funtion*
  • Supports Healthy Lipid Metabolism*

“Liver Health has been ”

The prevalence of NAFLD is continuously increasing worldwide due to factors such as obesity and hyperlipidemia.

1 in 3

worldwide are estimated to be
affected by NAFLD.1

40%

of males experience NAFLD, which is higher than the 26% rate among females.2

$1.34bn

The global liver health supplements market is predicted to grow to $1.34 billion by 2032 with a CAGR of 4.72% from 2024 to 2032.3

How does it work?

Preclinical studies demonstrate that MonaFit™ activates energy metabolism center, AMPK , which subsequently regulates mitochondria and transcription factors, thereby reducing liver fat and lowering AST and ALT levels,which are key markers of liver function.4

AMPK Activation
MonaFit™ effectively increases AMPK,the energy metabolism center

AMP-activated protein kinase (AMPK) modulates
lipid metabolism by inhibiting lipid synthesis and
promoting catabolic pathways such as lipolysis
and β-oxidation. MonaFit™ effectively increases
AMPK thereby reducing TG synthesis and promoting lipolysis.4

Maintains Healthy AST & ALT levels

A high-fat diet causes fat buildup in the liver, leading to liver cell damage and elevated serum ALT
and AST levels. MonaFit™ helps lower AST and ALT levels.4

Hepatic-Lipotropic Support

As daily fat intake increases,excess fatty acids in the liver are converted to triglycerides, forming fat droplets. MonaFit™ reduces liver cholesterol, triglycerides, and weight gain from a high-fat diet.4

Maintains Healthy AST & ALT levels

A high-fat diet causes fat buildup in the liver, leading to liver cell damage and elevated serum ALT
and AST levels. MonaFit™ helps lower AST and ALT levels.4

For Product Developer

The recommended dose of MonaFit for a healthy adult is one unit daily according to specific requirements.

Benefits of MonaFitTM for Liver
Health:

Supports Healthy liver funtion and Lipid
Metabolism*

Market-Ready Formula Concepts

The Scientifically Proven, Market-Ready Solution to Set Your Products Apart and Accelerate Your Success

Reference
  1. Review. J Hepatol. 2023 Sep;79(3):842-852.
  2. Review Clin Mol Hepatol . 2023 Feb;29(Suppl):S32-S42.
  3. Zion Market Research, 2024.
  4. In-house study
  5. Food Funct. 2025 Feb 3;16(3):966-985
Disclaimer

The communication is intended for business-to-business information and not for the final consumer. These statements have not been evaluated by
the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Contact Us